Abstract:ABSTRACT Antimicrobial resistance is one of the greatest challenges to global health. While the development of new antimicrobials can combat resistance, low profitability reduces the number of new compounds brought to market. Elucidating the mechanism of action is crucial for developing new antimicrobials. This can become expensive as there are no universally applicable pipelines. Phenotypic heterogeneity of microbial populations resulting from antimicrobial treatment can be captured through flow cytometric fingerprinting. Since antimicrobials are classified into limited groups, the mechanism of action of known compounds can be used for predictive modeling. We demonstrate a cost-effective flow cytometry approach for determining the mechanism of action of new compounds. Cultures of Actinomyces viscosus and Fusobacterium nucleatum were treated with different antimicrobials and measured by flow cytometry. A Gaussian mixture mask was applied over the data to construct phenotypic fingerprints. Fingerprints were used to assess statistical differences between mechanism of action groups and to train random forest classifiers. Classifiers were then used to predict the mechanism of action of cephalothin. Statistical differences were found among the different mechanisms of action groups. Pairwise comparison showed statistical differences for 35 out of 45 pairs for A. viscosus and for 32 out of 45 pairs for F. nucleatum after 3.5 h of treatment. The best-performing random forest classifier yielded a Matthews correlation coefficient of 0.92 and the mechanism of action of cephalothin could be successfully predicted. These findings suggest that flow cytometry can be a cheap and fast alternative for determining the mechanism of action of new antimicrobials. IMPORTANCE In the context of the emerging threat of antimicrobial resistance, the development of novel antimicrobials is a commonly employed strategy to combat resistance. Elucidating the mechanism of action of novel compounds is crucial in this development but can become expensive, as no universally applicable pipelines currently exist. We present a novel flow cytometry-based approach capable of determining the mechanism of action swiftly and cost-effectively. The workflow aims to accelerate drug discovery and could help facilitate a more targeted approach for antimicrobial treatment of patients.

What problem does this paper attempt to address?

The main issue this paper attempts to address is the high cost of mechanism research in the development of antimicrobial drugs. Specifically, the development of antimicrobial drugs faces the following challenges: 1. **Antimicrobial Resistance (AMR)**: This is one of the biggest challenges to global health. Although developing new antimicrobial drugs can combat resistance, the low profitability has led to a decrease in the number of new compounds on the market. 2. **High Cost of Mechanism Research**: Elucidating the mechanism of action (MOA) of new antimicrobial drugs is crucial for their development, but the lack of a universal methodological process makes the research very costly. To address these challenges, the authors propose a low-cost method based on flow cytometry to rapidly determine the mechanism of action of new antimicrobial drugs. This method accelerates the development process of antimicrobial drugs by constructing phenotypic fingerprints of microbial populations and using a random forest classifier for prediction. ### Main Research Content - **Background**: Antimicrobial resistance is a serious global health issue, and developing new antimicrobial drugs is an important strategy to address this problem. However, the high cost and low profitability of new drug development have led to a decrease in the number of new compounds on the market. Elucidating the mechanism of action of new compounds is crucial for drug development, but the lack of a universal methodological process makes the research costly. - **Method**: The authors used flow cytometry to treat two types of bacteria (Actinomyces viscosus and Fusobacterium nucleatum) and assessed their phenotypic characteristics in a high-throughput manner. Phenotypic fingerprints were constructed using a Gaussian mixture model, and a random forest classifier was trained to predict the mechanism of action of new compounds. - **Results**: The study showed that the phenotypic fingerprints of bacteria treated with antimicrobial drugs of different mechanisms of action can be clearly distinguished. The random forest classifier successfully predicted the mechanism of action of an unseen compound (cephalothin). - **Significance**: This method provides a rapid, low-cost alternative for determining the mechanism of action of new antimicrobial drugs, helping to accelerate the drug discovery process and potentially promoting more precise antimicrobial therapy for patients. ### Conclusion Phenotypic fingerprints constructed by flow cytometry can effectively distinguish antimicrobial drugs with different mechanisms of action, and the random forest classifier can successfully predict the mechanism of action of new compounds. This method is expected to become a cost-effective tool to accelerate the development and clinical application of antimicrobial drugs.

Unlocking the mechanism of action: a cost-effective flow cytometry approach for accelerating antimicrobial drug development

High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds

Rapid cytometric antibiotic susceptibility testing utilizing adaptive multidimensional statistical metrics.

Real-time flow cytometry to assess qualitative and quantitative responses of oral pathobionts during exposure to antiseptics

Metabolic Fingerprinting with Fourier-Transform Infrared (FTIR) Spectroscopy: Towards a High-Throughput Screening Assay for Antibiotic Discovery and Mechanism-of-Action Elucidation

Early detection of drug-resistant Streptococcus pneumoniae and Haemophilus influenzae by quantitative flow cytometry

Detection of antimicrobial resistance in <5 h in Neisseria gonorrhoeae isolates using flow cytometry—proof of concept for seven clinically relevant antimicrobials

Single-cell scattering and auto-fluorescence-based fast antibiotic susceptibility testing for gram-negative and gram-positive bacteria

A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing

Classification of antimicrobial mechanism of action using dynamic bacterial morphology imaging

Deep learning and single-cell phenotyping for rapid antimicrobial susceptibility detection in Escherichia coli

Real-Time Biosynthetic Reaction Monitoring Informs the Mechanism of Action of Antibiotics

Measuring autofluorescence spectral signatures for detecting antibiotic-resistant bacteria using Bigfoot spectral flow cytometer

Towards routine employment of computational tools for antimicrobial resistance determination via high-throughput sequencing

Recent Development of Rapid Antimicrobial Susceptibility Testing Methods through Metabolic Profiling of Bacteria

Flow cytometry, a powerful novel tool to rapidly assess bacterial viability in metal working fluids: Proof-of-principle

Metabolic-Activity-Based Assessment of Antimicrobial Effects by D2O-Labeled Single-Cell Raman Microspectroscopy

MICy: a Novel Flow Cytometric Method for Rapid Determination of Minimal Inhibitory Concentration

ADP-MoA: a platform for screening antibiotic activity and their mechanism of action in

High-Throughput Monitoring of Pathogenic Fungal Growth Using Whole Slide Imaging for Rapid Antifungal Susceptibility Assessment

Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations